Vironova AB (publ) granted US patent for a Thionation reagent.

STOCKHOLM, SWEDEN – Vironova AB, a leading Nano-Characterization technology and software company announced the approval of a new patent application. The US Patent Office (USPTO) has granted Vironova a patent for a Thionation reagent (no 13/936423).

This patent is expected to be valid until 2032. Corresponding patents have been applied for all major markets. Based on this innovation, Vironova continues to develop the technology for the US market where a number of chemical and pharmaceutical companies are stationed.

"The approval of this patent gives us a long-term US patent protection for our technology, a technology that can be used in the chemical industry but also for modifying pharmaceutical compounds. The patent is an important component in our strategy to develop new drugs with improved properties," says Mohammed Homman, Founder and CEO of Vironova AB.

For further information please contact:

Thomas Ahlerup

Head of Media Relations

H+K Strategies Sweden

Mobile: +46-768-966 300

E-mail: thomas.ahlerup@hkstrategies.com

Notes to the editor about Vironova AB (publ).

Vironova AB (publ) is a leading edge Nano-technology company with office and laboratories in Stockholm, Sweden, founded in 2005 by Mohammed Homman at the Karolinska Institute. Vironova has approximately 30 Employees, where 60 percent hold at least PhD's. Vironova offer solutions for image analysis for characterization and quality control of Nano sized particles. Vironova was founded focusing on virus screening but are now expanding into other areas e.g.: Semiconductors, Oil and gas, Mining and Material science. Vironova offer a full product portfolio with: Proprietary Electron Microscopes (EM), cameras, software and quality assured services. The company consists of two business areas; Services and instruments. Services - delivers an over all solution for Nano characterization with GXP quality assurance system. Instruments - a tabletop TEM with automated imaging and image analysis. A dedicated image analysis software

Vironova AB is a public is a public company.

For more information, please visit http://www.virinova.com

Please also visit our newsroom at http://www.mynewsdesk.com/se/bts